Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate

NCT00203047 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

414

Enrollment

INDUSTRY

Sponsor class

Stopped Slow enrollment decreased sample size; No unexpected safety issues.

Conditions

Relapsing Remitting Multiple Sclerosis

Interventions

DRUG: Glatiramer Acetate
DRUG: Placebo
DRUG: Prednisone

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.